Bafna Pharmaceuticals Ltd

📊 Bafna Pharmaceuticals Announces Board Committee Changes Following Director Retirement

• Mr. Palamadai Krishnan Sundaresan (DIN: 06954189) retires as Independent Director effective June 24, 2025.

• He steps down as Chairman of the Audit Committee and Member of the Nomination & Remuneration Committee.

• New Audit Committee: Mr. Navin Kumar (Chairman, Independent), Mrs. Ravichandran Chitra (Member, Independent), Mr. Upendar Mekala Reddy (Member, Non-Independent).

• New Nomination & Remuneration Committee: Mrs. Ravichandran Chitra (Chairperson, Independent), Mr. Navin Kumar (Member, Independent), Mrs. Akila Chintalapati Raju (Member, Non-Independent).

• Board and committees remain compliant with applicable laws post-retirement.